Publications in collaboration with researchers from Instituto de Investigación Sanitaria Biocruces Bizkaia (16)

2024

  1. Effects of cannabidiol in post-stroke mood disorders in neonatal rats

    Pediatric Research, Vol. 95, Núm. 7, pp. 1783-1790

  2. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

2023

  1. The Role of the Dopamine System in Post-Stroke Mood Disorders in Newborn Rats

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Glutamate, Glutamatergic Drugs and Schizophrenia

    Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Springer International Publishing), pp. 493-521

2021

  1. Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment

    Translational Psychiatry, Vol. 11, Núm. 1

  2. Opposite alterations of 5­HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

    Translational Psychiatry, Vol. 11, Núm. 1

  3. Subcellular specificity of cannabinoid effects in striatonigral circuits

    Neuron, Vol. 109, Núm. 9, pp. 1513-1526.e11

  4. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2019

  1. Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia

    Journal of Psychopharmacology, Vol. 33, Núm. 9, pp. 1132-1140

  2. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463

2018

  1. The endocannabinoid system in mental disorders: Evidence from human brain studies

    Biochemical Pharmacology, Vol. 157, pp. 97-107

2017

  1. Antipsychotic-induced Hdac2 transcription via NF-ΰ B leads to synaptic and cognitive side effects

    Nature Neuroscience, Vol. 20, Núm. 9, pp. 1247-1259

2014

  1. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment

    Neuropharmacology, Vol. 86, pp. 311-318

2013

  1. Antidepressant-like properties of three new α2-adrenoceptor antagonists

    Neuropharmacology, Vol. 65, pp. 13-19

  2. Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

    European Neuropsychopharmacology, Vol. 23, Núm. 8, pp. 852-864

  3. Quantification of endocannabinoids in postmortem brain of schizophrenic subjects

    Schizophrenia Research, Vol. 148, Núm. 1-3, pp. 145-150